Kalytera Completes Deferral Transaction with Former Shareholders of Talent Biotechs
February 08, 2019 20:54 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO, and TEL AVIV, Israel, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today completed certain...
Kalytera Announces Change to Scope of Services under Payments Agreements with Salzman Group and Next Share Issuance
January 31, 2019 14:23 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that the Company...
Kalytera Announces Grant of Stock Options to Certain Directors and Employees
January 28, 2019 13:35 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, ISRAEL , Jan. 28, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that it has...
Kalytera Announces Closing of Private Placement of Common Shares and Common Share Purchase Warrants
January 22, 2019 17:58 ET
|
Kalytera Therapeutics, Inc.
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. SAN FRANCISCO...
Kalytera Announces Closing of Private Placement of Common Shares and Common Share Purchase Warrants
January 15, 2019 20:19 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this...
Kalytera Announces Share Issuance and Extension to March 1 under Payments Agreements with Salzman Group
January 14, 2019 15:34 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that the Company...
Kalytera Announces Private Placement of Common Shares and Common Share Purchase Warrants
January 11, 2019 11:13 ET
|
Kalytera Therapeutics, Inc.
/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ SAN FRANCISCO and TEL AVIV, Israel, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (the “Company” or...
Kalytera Announces Private Placement of Common Shares and Common Share Purchase Warrants
December 18, 2018 21:26 ET
|
Kalytera Therapeutics, Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES SAN FRANCISCO and TEL AVIV, Israel, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (the “Company” or...
Kalytera Announces Additional Share Issuance for Services under Payments Agreement with Salzman Group
December 04, 2018 13:02 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that the Company...
Kalytera Reports Third Quarter 2018 Financial Results
November 30, 2018 07:30 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today reported financial results...